Novel Therapeutic Approaches for Migraine Headaches
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 July 2025 | Viewed by 2164
Special Issue Editors
Interests: minimally invasive approaches for migraines; occipital neuralgia; nerve decompression surgery; migraines; cluster headaches; botulinum toxin
Special Issue Information
Dear Colleagues,
Migraines and chronic headaches remain among the most disabling conditions. Novel approaches, ranging from new pharmacologic and molecular therapeutics to novel, more effective protocols of already-used drugs such as botulinum toxin and anti-CGRPs are highly warranted to help migraines. In some conditions such as occipital neuralgia, normally considered very rare, there is a clear dysfunction of the occipital nerves, but there is a lack of effective treatment options, with this condition remaining largely underestimated. Cluster headaches are rarer but are among the worst and most intense types of headaches; more effective strategies of treatment are highly needed.
This Special Issue aims to bring together clinical experts to develop guidelines for the diagnosis and treatment of migraine, chronic headaches, cluster headaches occipital neuralgia and neurological disorders, focusing on insights and advances at the genetic and molecular levels.
Dr. Giorgio Pietramaggiori
Dr. Saja Scherer
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- migraines
- chronic headaches
- cluster headaches
- occipital neuralgia
- neuralgia
- occipital nerve dysfunction
- nerve damage
- botulinum toxin
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
